// App-Quantinova.ai

843 : The cost effectiveness of a policy of universal aspirin versus aspirin indicated by a positive pre-eclampsia screening test

Researchers

Presenter

  • James F. O'Mahony

Principal Investigators

  • Fionnuala Mone

  • Ella Tyrrell

  • Cecilia Mulcahy

  • Peter McParland

  • Fionnuala Breathnach

  • John J. Morrison

  • John Higgins

  • Sean Daly

  • Amanda Cotter

  • Alyson Hunter

  • Patrick Dicker

  • Elizabeth Tully

  • Fergal D. Malone

  • Charles Normand

  • Fionnuala M. McAuliffe

Medical Centers

  • Health Policy and Management, Trinity College Dublin Dublin Ireland

  • UCD Perinatal Research Centre, UCD Obstetrics and Gynaecology, School of Medicine, National Maternity Hospital, University College Dublin, Dublin, Ireland

  • Department of Fetal Medicine, National Maternity Hospital, Dublin, Ireland

  • Department of Obstetrics & Gynaecology, Royal College of Surgeons in Ireland, Rotunda Hospital, Dublin, Ireland

  • The National University of Ireland, Galway, Ireland

  • Department of Obstetrics and Gynaecology, University College Cork, Cork, Ireland

  • Department of Pathology, Coombe Women and Infants University Hospital, Dublin, Ireland

  • Obstetrics & Gynaecology, Graduate Entry Medical School, University of Limerick, Limerick, Munster, Ireland

  • Anaesthetics, Royal Jubliee Maternity Hospital,Belfast, United Kingdom

Locations

  • Ireland

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Obstetrics/Gynecology

Disease

  • Preeclampsia

Biomarkers

  • N/A

Drug/Treatment

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • Randomized

  • Multicenteric

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved